AzTrials
AzTrials

Heart Defects, CongenitalNCT07055334

Development and Improvement of Home Rehabilitation Scheme for Preschool Children With Congenital Heart Disease After Operation

An observational study of Heart Defects, Congenital and Rehabilitation, run by Wei XIA, PhD at 1 site in China.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This part of the study focuses on understanding the home rehabilitation situation for preschool children with congenital heart disease after operation. Qualitative research interviews with caregivers and medical staff (including doctors, nurses, rehabilitation therapists, nutritionists, and psychologists) are… Read more about this study

Who is it for?
Ages 3 years and olderHealthy volunteers can take part
How many people
30 participants
Where
1 siteChina
Study dates
10 Jul 2025to 31 Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: This study includes three groups. For children with congenital heart disease after surgery, inclusion criteria are age 3 to 7, one-time corrective open-heart surgery in the research unit, and ability to communicate in Chinese. Exclusions are arrhythmia after surgery, other diseases unsuitable for exercise, heart function class IV, and perioperative disorders. For caregivers, must be main caregiver, volunteer, spend most time caring, and communicate in Chinese. Exclusions are those who give up treatment, are paid caregivers, have cognitive impairment or mental illness, cannot express feelings, have contradictions with child, or cannot use electronic devices. For medical professionals, must hold license and have at least 5 years of related practice. Exclusions are non-frontline staff or those absent in recent year.

Who may be able to join

  • Age 3 to 7 years
  • Clinical diagnosis of congenital heart disease
  • Underwent a single open-heart surgical correction under direct vision at the study site
  • Ability to communicate in Chinese
  • Primary caregiver who voluntarily provides care
  • Caregiver who spends the most time with the child
Show all 9Show fewer
  • Ability to communicate in Chinese
  • Licensed healthcare professionals, including physicians, nurses, dietitians, physical therapists, or psychological counselors
  • At least 5 years of professional experience in congenital heart disease care, rehabilitation, or education

Who cannot join

  • Postoperative arrhythmia
  • Comorbid neurological, respiratory, or other systemic diseases
  • Deemed unsuitable for exercise by a physician
  • Cardiac function classified as NYHA Class IV
  • Intellectual, language, or motor impairments resulting from perioperative complications or other causes
  • Caregivers of Children With Congenital Heart Disease After Surgery
Show all 15Show fewer
  • Caregivers of children who voluntarily discontinued treatment before completion
  • Paid or professional caregivers
  • Diagnosed cognitive impairment or mental illness
  • Inability to communicate effectively through spoken language
  • Presence of serious conflict or instability in the caregiver-child relationship
  • Inability to independently operate or use smart electronic devices and the internet
  • Medical Professionals Involved in Congenital Heart Disease Care
  • Not currently engaged in frontline clinical work
  • Not engaged in clinical work within the past year due to leave, study, or reassignment

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

China1 site
  • Sun Yat-sen University

    Guangzhou, Guangdong, 510080

Other trials in China

About this study

This part of the study focuses on understanding the home rehabilitation situation for preschool children with congenital heart disease after operation. Qualitative research interviews with caregivers and medical staff (including doctors, nurses, rehabilitation therapists, nutritionists, and psychologists) are conducted to explore the benefits, obstacles, and professional guidance needs of home rehabilitation. The aim is to summarize the best evidence for home rehabilitation through evidence-based nursing and qualitative research, in order to develop a more comprehensive and suitable home rehabilitation scheme for these children.

Keywords
congenital heart disease, home-based cardiac rehabilitation, Primary caregiver, qualitative research, preschool child
Medical subject headings
Heart Defects, Congenital

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Core Components Finalized in the Home Rehabilitation Scheme Based on Expert Consensus

    The home rehabilitation scheme will be developed using a two-round Delphi method with a multidisciplinary expert panel. Each proposed module will be rated by experts for its relevance, feasibility, and clarity. Components reaching ≥75% agreement (rated as "agree" or "strongly agree") will be considered finalized. The outcome will be reported as the number and percentage of components finalized out of all proposed components.

    Measured: 12 months (from initiation to completion of scheme development)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jul 2025
  2. Study start10 Jul 2025 (estimated)
  3. Primary completion1 Dec 2025 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07055334
Sponsor's protocol ID
LSLL2024-801
Status last verified
Jun 2025
First submitted
5 Jun 2025
Last updated
8 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Heart Defects, Congenital and Rehabilitation, run by Wei XIA, PhD at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 8 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Xia Wei, PhD (+8618823359471, xiaw23@mail.sysu.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Core Components Finalized in the Home Rehabilitation Scheme Based on Expert Consensus (time frame: 12 months (from initiation to completion of scheme development)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in